Phase 1 study of capmatinib in MET-positive solid tumor patients: Dose escalation and expansion of selected cohorts

10.1111/cas.14254

Saved in:
Bibliographic Details
Main Authors: Bang, Yung-Jue, Su, Wu-Chou, Schuler, Martin, Nam, Do-Hyun, Lim, Wan Teck, Bauer, Todd M, Azaro, Analia, Poon, Ronnie Tung Ping, Hong, David, Lin, Chia-Chi, Akimov, Mikhail, Ghebremariam, Samson, Zhao, Sylvia, Giovannini, Monica, Ma, Brigette
Other Authors: DUKE-NUS MEDICAL SCHOOL
Format: Article
Language:English
Published: WILEY 2022
Subjects:
Online Access:https://scholarbank.nus.edu.sg/handle/10635/218537
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
Language: English
id sg-nus-scholar.10635-218537
record_format dspace
spelling sg-nus-scholar.10635-2185372024-11-11T21:42:40Z Phase 1 study of capmatinib in MET-positive solid tumor patients: Dose escalation and expansion of selected cohorts Bang, Yung-Jue Su, Wu-Chou Schuler, Martin Nam, Do-Hyun Lim, Wan Teck Bauer, Todd M Azaro, Analia Poon, Ronnie Tung Ping Hong, David Lin, Chia-Chi Akimov, Mikhail Ghebremariam, Samson Zhao, Sylvia Giovannini, Monica Ma, Brigette DUKE-NUS MEDICAL SCHOOL Assoc Prof Wan-Teck Darren Lim Science & Technology Life Sciences & Biomedicine Oncology capmatinib MET amplification MET dysregulation phase 1 solid tumors CELL LUNG-CANCER MOLECULE INHIBITORS BINDING C-MET PHARMACOPHORE APPROACH ACQUIRED-RESISTANCE KINASE INHIBITOR TARGETING MET AMPLIFICATION SENSITIVITY MUTATIONS 10.1111/cas.14254 CANCER SCIENCE 111 2 536-547 2022-04-07T04:41:48Z 2022-04-07T04:41:48Z 2019-12-30 2022-04-07T02:17:06Z Article Bang, Yung-Jue, Su, Wu-Chou, Schuler, Martin, Nam, Do-Hyun, Lim, Wan Teck, Bauer, Todd M, Azaro, Analia, Poon, Ronnie Tung Ping, Hong, David, Lin, Chia-Chi, Akimov, Mikhail, Ghebremariam, Samson, Zhao, Sylvia, Giovannini, Monica, Ma, Brigette (2019-12-30). Phase 1 study of capmatinib in MET-positive solid tumor patients: Dose escalation and expansion of selected cohorts. CANCER SCIENCE 111 (2) : 536-547. ScholarBank@NUS Repository. https://doi.org/10.1111/cas.14254 13479032 13497006 https://scholarbank.nus.edu.sg/handle/10635/218537 en WILEY Elements
institution National University of Singapore
building NUS Library
continent Asia
country Singapore
Singapore
content_provider NUS Library
collection ScholarBank@NUS
language English
topic Science & Technology
Life Sciences & Biomedicine
Oncology
capmatinib
MET amplification
MET dysregulation
phase 1
solid tumors
CELL LUNG-CANCER
MOLECULE INHIBITORS BINDING
C-MET
PHARMACOPHORE APPROACH
ACQUIRED-RESISTANCE
KINASE INHIBITOR
TARGETING MET
AMPLIFICATION
SENSITIVITY
MUTATIONS
spellingShingle Science & Technology
Life Sciences & Biomedicine
Oncology
capmatinib
MET amplification
MET dysregulation
phase 1
solid tumors
CELL LUNG-CANCER
MOLECULE INHIBITORS BINDING
C-MET
PHARMACOPHORE APPROACH
ACQUIRED-RESISTANCE
KINASE INHIBITOR
TARGETING MET
AMPLIFICATION
SENSITIVITY
MUTATIONS
Bang, Yung-Jue
Su, Wu-Chou
Schuler, Martin
Nam, Do-Hyun
Lim, Wan Teck
Bauer, Todd M
Azaro, Analia
Poon, Ronnie Tung Ping
Hong, David
Lin, Chia-Chi
Akimov, Mikhail
Ghebremariam, Samson
Zhao, Sylvia
Giovannini, Monica
Ma, Brigette
Phase 1 study of capmatinib in MET-positive solid tumor patients: Dose escalation and expansion of selected cohorts
description 10.1111/cas.14254
author2 DUKE-NUS MEDICAL SCHOOL
author_facet DUKE-NUS MEDICAL SCHOOL
Bang, Yung-Jue
Su, Wu-Chou
Schuler, Martin
Nam, Do-Hyun
Lim, Wan Teck
Bauer, Todd M
Azaro, Analia
Poon, Ronnie Tung Ping
Hong, David
Lin, Chia-Chi
Akimov, Mikhail
Ghebremariam, Samson
Zhao, Sylvia
Giovannini, Monica
Ma, Brigette
format Article
author Bang, Yung-Jue
Su, Wu-Chou
Schuler, Martin
Nam, Do-Hyun
Lim, Wan Teck
Bauer, Todd M
Azaro, Analia
Poon, Ronnie Tung Ping
Hong, David
Lin, Chia-Chi
Akimov, Mikhail
Ghebremariam, Samson
Zhao, Sylvia
Giovannini, Monica
Ma, Brigette
author_sort Bang, Yung-Jue
title Phase 1 study of capmatinib in MET-positive solid tumor patients: Dose escalation and expansion of selected cohorts
title_short Phase 1 study of capmatinib in MET-positive solid tumor patients: Dose escalation and expansion of selected cohorts
title_full Phase 1 study of capmatinib in MET-positive solid tumor patients: Dose escalation and expansion of selected cohorts
title_fullStr Phase 1 study of capmatinib in MET-positive solid tumor patients: Dose escalation and expansion of selected cohorts
title_full_unstemmed Phase 1 study of capmatinib in MET-positive solid tumor patients: Dose escalation and expansion of selected cohorts
title_sort phase 1 study of capmatinib in met-positive solid tumor patients: dose escalation and expansion of selected cohorts
publisher WILEY
publishDate 2022
url https://scholarbank.nus.edu.sg/handle/10635/218537
_version_ 1821214524712157184